Aquestive Therapeutics, Inc. (AQST)
4.24
+0.01
(+0.24%)
USD |
NASDAQ |
May 07, 16:00
4.24
0.00 (0.00%)
After-Hours: 19:28
Aquestive Therapeutics Free Cash Flow : -52.99M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Nektar Therapeutics | -208.68M |
| REGENXBIO, Inc. | -126.38M |
| Verastem, Inc. | -147.13M |
| Harrow, Inc. | 42.76M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.469M |
| Cash from Investing (Quarterly) | -0.085M |
| Cash from Financing (Quarterly) | 0.66M |
| Free Cash Flow Per Share (Quarterly) | -0.0701 |
| Free Cash Flow to Equity (Quarterly) | -11.14M |
| Free Cash Flow to Firm (Quarterly) | -4.281M |
| Free Cash Flow Yield | -11.70% |